InspireMD (NSPR) Shares Gap Down to $0.19

InspireMD Inc (NYSEAMERICAN:NSPR) gapped down prior to trading on Monday . The stock had previously closed at $0.21, but opened at $0.19. InspireMD shares last traded at $0.17, with a volume of 2938318 shares.

A hedge fund recently raised its stake in InspireMD stock. Virtu Financial LLC grew its position in shares of InspireMD Inc (NYSEAMERICAN:NSPR) by 1,305.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 291,021 shares of the medical equipment provider’s stock after acquiring an additional 270,318 shares during the quarter. Virtu Financial LLC owned about 0.77% of InspireMD worth $46,000 as of its most recent filing with the Securities & Exchange Commission.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.com-unik.info/2019/02/11/inspiremd-nspr-shares-gap-down-to-0-19.html.

About InspireMD (NYSEAMERICAN:NSPR)

InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.

Featured Article: What is the Dividend Aristocrat Index?

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit